Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,364 recruiting studies in this area right now.
By phase
- Not applicable9,630
- Phase 24,440
- Phase 12,682
- Phase 1/Phase 21,657
- Phase 31,400
- Phase 2/Phase 3286
- Phase 4269
Top conditions
- Breast Cancer1,208
- Prostate Cancer651
- Cancer636
- Colorectal Cancer475
- Lung Cancer420
- Ovarian Cancer341
- Multiple Myeloma327
- Pancreatic Cancer289
- Gastric Cancer285
- Acute Myeloid Leukemia280
- Hepatocellular Carcinoma260
- Solid Tumor246
- Advanced Solid Tumor229
- Head and Neck Cancer228
- Cervical Cancer223
- Endometrial Cancer212
- Advanced Solid Tumors210
- Esophageal Cancer190
Leading sponsors
- M.D. Anderson Cancer Center460
- Fudan University306
- National Cancer Institute (NCI)293
- Memorial Sloan Kettering Cancer Center290
- Sun Yat-sen University276
- Mayo Clinic237
- City of Hope Medical Center146
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences145
- AstraZeneca133
- Ruijin Hospital130
Where studies are running
- California1,397
- Texas638
- Arizona504
- Florida440
- Alabama430
- New York404
- Massachusetts341
- Maryland329
- New Jersey275
- Pennsylvania234
Recruiting studies20,364 total
- NCT01746836RecruitingPhase 2
Ponatinib for CML that didn’t respond to prior pills
This trial studies ponatinib as a second treatment for chronic myeloid leukemia (CML) when it didn’t fully respond or couldn’t be tolerated with at least one prior CML pill. It aims to see whether ponatinib can better control leukemia levels after earlier treatments.
Houston, TexasAges 18 years+ - NCT01804634RecruitingPhase 2
Reduced-intensity stem cell transplant for high-risk solid tumors
This trial tests a less intense type of bone marrow (stem cell) transplant from a partly matched family donor for people with high-risk solid tumors. It aims to lower treatment intensity while still using the donor’s immune system to help control the cancer.
Baltimore, MarylandAges 1–50 - NCT00571389Recruiting
Collecting blood cells from people with cancer or COVID-19
This study collects blood cells using a special blood-draw procedure called leukapheresis (for some participants) and other samples. It aims to better understand cancer and immune-related cells, which may help researchers design or improve future treatments.
Huntersville, North CarolinaAges 5 years+ - NCT01255748Recruiting
Registry study tracking outcomes after radiation treatment
This registry study collects information from people who are planning to receive radiation therapy. The goal is to better understand treatment outcomes and help improve radiation care over time.
Scottsdale, ArizonaAges Any age - NCT00969111Recruiting
Radiation after prostate surgery for prostate cancer without nodal spread
This trial looks at radiation therapy given after prostate surgery (or if needed later) for prostate cancer where lymph nodes were not involved. It may help patients whose PSA rises or who need additional treatment to reduce the chance the cancer comes back.
Little Rock, ArkansasAges 18 years+ - NCT00539162Recruiting
CA-125 and other tests to check for early ovarian cancer risk
This study looks at how well a blood test called CA-125, along with other markers and checkups, can detect ovarian cancer early. It’s for women considered low risk who will do regular blood tests and possibly a vaginal ultrasound if results suggest it.
Miami, FloridaAges 50–74 - NCT00870129Recruiting
MRI mapping to plan radiation for certain brain tumors
This study uses MRI scans to find higher-risk areas in certain brain and other solid tumors and help plan radiation treatment. It also looks for changes in tumor “metabolites” (chemicals in the tumor) that may relate to how the tumor behaves.
New York, New YorkAges 18 years+ - NCT00260559Recruiting
Checks quality of life after esophagus surgery
This study looks at outcomes and quality of life after esophagus removal surgery, comparing minimally invasive surgery and open surgery. It may help doctors understand how different surgical approaches affect how you feel during recovery.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT00349830Recruiting
Blood marker test to track response to cancer treatment
This study looks for new blood (serum) markers that may show whether anti-cancer therapy is working. If you have cancer or possible cancer and can safely take part, your blood may be used to monitor treatment response over time.
Stanford, CaliforniaAges 18 years+ - NCT00669266Recruiting
Study of adrenal tumors—causes and possible treatments
This study looks at adrenal tumors found on imaging (scans) to better understand what causes them and how they might be treated. If you have an adrenal tumor on a scan, this trial may be looking to enroll you for that purpose.
WürzburgAges Up to 100 years - NCT00704626Enrolling by invitation
Blood antibody tests in autoimmune brain and nerve diseases
This study looks at blood “auto-antibodies,” which are immune proteins that may attack the body, in people with certain brain and nerve conditions. It may help researchers better understand these diseases and how the immune system is involved.
Sacramento, CaliforniaAges 18 years+ - NCT00684580Recruiting
St. Jude childhood cancer follow-up data study
This study collects information from children who are currently being treated or followed at St. Jude for childhood cancer. It helps researchers understand care outcomes and improve future planning.
Memphis, TennesseeAges Any age - NCT00756665Recruiting
Study of careful monitoring for prostate cancer
This study follows people with early-stage prostate cancer who choose active surveillance instead of immediate treatment. It aims to see how monitoring with repeat prostate biopsies and follow-up works over time.
San Francisco, CaliforniaAges 21 years+ - NCT00301119Recruiting
Lung cancer screening using risk factors and test results
This study looks at how to find lung cancer earlier by screening people based on their lung-cancer risk. It may help doctors decide who needs further testing if lung nodules are found.
New York, New YorkAges 50 years+ - NCT00588185Recruiting
Pet scans for advanced prostate or salivary gland cancer
This study uses special PET scans to get a detailed picture of prostate or salivary gland cancer that is getting worse. The scans may help doctors see the cancer more clearly and plan better treatment.
Basking Ridge, New JerseyAges Any age - NCT00505245Recruiting
Testing a new way to measure cancer symptom distress
This study tests a new assessment system (a set of questions/tools) to better measure how much distress cancer patients feel from symptoms. It may help cancer teams better understand your symptom burden and improve support.
Houston, TexasAges 18 years+ - NCT00896935Recruiting
Donate cancer tissue and blood samples for research
This study lets people with cancer who are getting a procedure at the Arizona Cancer Center or University Medical Center contribute tissue or blood samples for research. Your samples help researchers learn about cancer and may support future studies.
Tucson, ArizonaAges 18 years+ - NCT00730678Recruiting
Study genes to learn how treatment affects children
This study looks at genetic (DNA) differences to better understand why treatments work differently for children at St. Jude. It may help doctors choose safer or more effective treatments in the future.
Memphis, TennesseeAges Any age - NCT00501826RecruitingPhase 2
Check nelarabine plus chemotherapy for T-cell blood cancers
This trial tests a combination of chemotherapy with nelarabine in people with T-cell acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma. It may help by improving remission in newly diagnosed or certain previously treated patients whose disease did not respond after one initial treatment.
Houston, TexasAges Any age - NCT00662090Recruiting
Study of blood disorders in children with MDS or JMML
This study looks at two childhood blood disorders—myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML). The goal is to describe how these conditions work in children and better understand them over time.
Freiburg im Breisgau, Baden-WurttembergAges Up to 17 years - NCT00801489RecruitingPhase 2
New treatment for AML or high-risk MDS using combination chemo
This trial tests a combination treatment (chemo drugs plus a growth-factor medicine) for people newly diagnosed with acute myeloid leukemia (AML) or certain high-risk myelodysplastic syndromes (MDS). It may help by targeting cancer cells in the blood and bone marrow and improving remission chances.
Houston, TexasAges 18 years+ - NCT00899301Recruiting
Banking breast cancer and related tissue samples for future studies
This study collects and stores tissue and fluid samples from people with a breast lump or breast cancer so researchers can study cancer biology in the future. It may help future patients by allowing better lab tests and research on why breast cancer starts, grows, and comes back.
Nashville, TennesseeAges 18 years+ - NCT01050504Recruiting
Donate blood and tissue to study recurrent or metastatic cancers
This study collects and studies blood and, when possible, small tissue samples from people with prostate or bladder/urothelial cancer that has come back or spread. The goal is to better understand these cancers and support future research that may lead to better care.
Seattle, WashingtonAges 18 years+ - NCT00186147Enrolling by invitation
Bone marrow grafting for leukemia and lymphoma
This study involves bone marrow cell grafting for people affected by leukemia or lymphoma. You may be eligible if you are a transplant recipient or a donor and you freely choose to take part.
Stanford, CaliforniaAges 18–70
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,364 recruiting oncology studies from the U.S. registry right now, out of 31,668 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.